Copyright
©The Author(s) 2018.
World J Hepatol. Dec 27, 2018; 10(12): 898-906
Published online Dec 27, 2018. doi: 10.4254/wjh.v10.i12.898
Published online Dec 27, 2018. doi: 10.4254/wjh.v10.i12.898
Figure 1 Emergence of hepatocellular carcinoma (HCC) during and after treatment in direct-acting antiviral (DAA) era (upper part) and intreferon era (lower part).
It is uncertain whether HCC emerges in patients treated with DAA in more than 5 years after sustained virological response. DAA: direct-acting antiviral; HCC: hepatocellular carcinoma; HCV: hepatitis C virus; ISG: interferon-stimulated gene.
- Citation: Sasaki R, Kanda T, Kato N, Yokosuka O, Moriyama M. Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response. World J Hepatol 2018; 10(12): 898-906
- URL: https://www.wjgnet.com/1948-5182/full/v10/i12/898.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i12.898